Aortic valve replacement: Results and predictors of mortality from a contemporary series of 2256 patients Marco Di Eusanio, MD, PhD, Daniela Fortuna,

Slides:

Advertisements

Similar presentations

Operative outcomes in mitral valve surgery: Combined effect of surgeon and hospital volume in a population-based analysis Arman Kilic, MD, Ashish S.

Advertisements

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Of mice and men and surgical transcatheter aortic valve insertion

Manuel J. Antunes, MD, PhD, DSc

Clinical and hemodynamic outcomes of “all-comers” undergoing transapical aortic valve implantation: Results from the Italian Registry of Trans-Apical.

The fate of small-size pericardial heart valve prostheses in an older patient population Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Endoscopic Robotic Mitral Valve Surgery

When is the Ross operation a good option to treat aortic valve disease? Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc

Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis Akin Cam, MD, Sachin S. Goel, MD, Shikhar Agarwal, MD, MPH,

Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society.

Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age Torsten Christ,

Building a bioartificial heart: A 3-song saga

Surgical therapy for ischemic heart failure: Single-center experience with surgical anterior ventricular restoration Lorenzo Menicanti, MD, Serenella.

The fate of small-size pericardial heart valve prostheses in an older patient population Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Form ever follows function

Gilbert H. L. Tang, MD, MSc, Ramin Malekan, MD, Cindy J

William M. DeCampli, MD, PhD

How should we treat air leaks?

Bicuspid aortic valve aortopathy: One size fits all?

Short-term and long-term results of cardiac surgery in elderly and very elderly patients Giuseppe Speziale, MD, Giuseppe Nasso, MD, Maria Cristina Barattoni,

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Tom Kai Ming Wang, MBCHB, David H. M

Outcome after surgery for prosthetic valve endocarditis and the impact of preoperative treatment Herko Grubitzsch, MD, PhD, Andreas Schaefer, Christoph.

The variability of the mitral valve anatomy and terminology

John A. Elefteriades, MD, PhD (hon), Bulat A. Ziganshin, MD, PhD

Open aortic arch reconstruction after previous cardiac surgery: Outcomes of 168 consecutive operations Eduard Quintana, MD, FETCS, Pietro Bajona, MD,

Transcatheter aortic valve replacement in intermediate-risk patients

Innovation and science: The future of valve design

It's not “just a shunt” but sometimes it should be…

Michele Gallo, MD, Gino Gerosa, MD

Age alone should not preclude surgery: Contemporary outcomes after aortic valve replacement in nonagenarians Isaac George, MD, Halit Yerebakan, MD, Bindu.

The aortic valve–sparing operation

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Conventional redo biological valve replacement over 20 years: Surgical benchmarks should guide patient selection for transcatheter valve-in-valve therapy

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

Replicating the success of mitral valve repair in the aortic valve

Frozen elephant trunk technique: Ready to get back to the future?

Attachment disorder in thoracoabdominal surgery

Bradley G. Leshnower, MD, Robert A. Guyton, MD, Richard J

Commentary: Ongoing advancements in the understanding of tricuspid valve dynamics and functional geometry Daniel J.P. Burns, MD, MPhil The Journal of.

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Biomaterials for heart valve replacement: Conjectures and refutations

Hans-Joachim Schäfers, MD

Concomitant replacement of the ascending aorta is free—for some

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Aortic root reconstruction with a bioprosthetic valved conduit: A consecutive series of 275 procedures Christian D. Etz, MD, Tobias M. Homann, MS, Neil.

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Severe tricuspid or mitral regurgitation in inoperable patients with aortic stenosis. Can we leave them alone? Juan A. Crestanello, MD The Journal of.

The future of cardiac surgery training: A survival guide

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

The continuing challenge of congenital heart disease in China

Commentary: When a choice is not an echo

Between a rock and a hard place

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

Maral Ouzounian, MD, PhD, Amine Mazine, MD, MSc, Tirone E. David, MD

“The more things change…”: The challenges ahead

Toward a more rational approach in treating type B aortic dissection

Preoperative PFTs: The answer is blowing in the wind

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

Clinical and hemodynamic outcomes of “all-comers” undergoing transapical aortic valve implantation: Results from the Italian Registry of Trans-Apical.

Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Paul Philipp Heinisch, MD, Thierry Carrel, MD

Presentation transcript:

Aortic valve replacement: Results and predictors of mortality from a contemporary series of 2256 patients Marco Di Eusanio, MD, PhD, Daniela Fortuna, PhD, Rossana De Palma, MD, Andrea Dell'Amore, MD, Mauro Lamarra, MD, Giovanni A. Contini, MD, Tiziano Gherli, MD, Davide Gabbieri, MD, Italo Ghidoni, MD, Donald Cristell, MD, Claudio Zussa, MD, Florio Pigini, MD, Peppino Pugliese, MD, Davide Pacini, MD, Roberto Di Bartolomeo, MD The Journal of Thoracic and Cardiovascular Surgery Volume 141, Issue 4, Pages 940-947 (April 2011) DOI: 10.1016/j.jtcvs.2010.05.044 Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Three-year survival of the overall study population stratified according to NYHA class I–II and III–IV, and expected survival of age- and gender-matched 2006 regional population. Survival of patients in class III–IV is significantly lower than survival of patients in class I–II (log-rank P < .001) and expected survival. Survival of patients in class I–II is comparable to expected survival of age- and gender-matched 2006 regional population (log-rank P = .1634). NYHA, New York Heart Association. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 940-947DOI: (10.1016/j.jtcvs.2010.05.044) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Three-year survival of the study population according to age ≥ 80 or < 80 years. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 940-947DOI: (10.1016/j.jtcvs.2010.05.044) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Three-year survival of the octogenarian study population compared with expected survival of age- and gender-matched 2006 regional population (log-rank P = .157). AVR, Aortic valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 940-947DOI: (10.1016/j.jtcvs.2010.05.044) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions